InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by Karam Sammy, Vice-Président Senior. Director active across 1 companies, notably Abbott Laboratories. Aggregated, 7 filings have been logged. Total volume traded: €1.2m. The latest transaction was filed on 28 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
013,238 shares0
Common shares without par value
SEC:0001415889-22-002194:0·
€580,8374,700 shares@ €123.58230.0003% mcap36.1% of flow
Common shares without par value
SEC:0001415889-21-006264·
€580,8374,700 shares@ €123.58230.0003% mcap18.0% of flow
Common shares without par value
SEC:0001415889-21-006264:0·
€518,5438,000 shares@ €64.81780.0002% mcap32.2% of flow
Common shares without par value
SEC:0001415889-21-004019·
€518,5438,000 shares@ €64.81780.0002% mcap16.1% of flow
Common shares without par value
SEC:0001415889-21-004019:0·
€511,5668,000 shares@ €63.94570.0002% mcap31.8% of flow
Common shares without par value
SEC:0001415889-21-003804·
€511,5668,000 shares@ €63.94570.0002% mcap15.9% of flow
Common shares without par value
SEC:0001415889-21-003804:0·
7 of 7 declarations
About Karam Sammy
Sammy Karam is the Senior Vice President at Abbott Laboratories. He is responsible for managing operations and strategic development for the company. With significant experience in the pharmaceutical sector, Sammy Karam contributes to process optimization and growth at Abbott Laboratories. His leadership is essential for achieving the company's objectives.
